CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment

Bao, SS; Darvishi, M; Amin, A; Al-Haideri, MT; Patra, I; Kashikova, K; Ahmad, I; Alsaikhan, F; Al-qaim, ZH; Al-Gazally, ME; Kiasari, BA; Tavakoli-Far, B; Sidikov, AA; Mustafa, YF; Akhavan-Sigari, R

Kiasari, BA (通讯作者)，Univ Tehran, Fac Vet Med, Virol Dept, Tehran, Iran.;Tavakoli-Far, B (通讯作者)，Alborz Univ Med Sci, Dietary Supplements & Probiot Res Ctr, Karaj, Iran.;Tavakoli-Far, B (通讯作者)，Alborz Univ Med Sci, Fac Med, Dept Physiol & Pharmacol, Karaj, Iran.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; ():

Abstract

CXC chemokine receptor type 4 (CXCR4) is a member of the G protein-coupled receptors (GPCRs) superfamily and is specific for CXC chemokine ligand 12 (......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索